about
First trimester in utero exposure to methylphenidateAlcohol and breastfeedingThe antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart diseaseDrug interaction databases in medical literature: transparency of ownership, funding, classification algorithms, level of documentation, and staff qualifications. A systematic review.Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6.Methylphenidate and pregnancy.[The treatment of hyperemesis gravidarum with chlorobutanol-caffeine rectal suppositories in Denmark: practice and evidence].CYP2D6 genotyping and tamoxifen in the treatment of post-menopausal breast cancerStatins and breast cancer prognosis: evidence and opportunities.Pharmacological treatment of unipolar depression during pregnancy and breast-feeding--a clinical overview.Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study.Abuse Potential of Pregabalin: A Systematic Review.SearCh for humourIstic and Extravagant acroNyms and Thoroughly Inappropriate names For Important Clinical trials (SCIENTIFIC): qualitative and quantitative systematic study.Escitalopram is a weak inhibitor of the CYP2D6-catalyzed O-demethylation of (+)-tramadol but does not reduce the hypoalgesic effect in experimental pain.Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone.Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversyThe European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal productThe impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide.The effects of human CYP2C8 genotype and fluvoxamine on the pharmacokinetics of rosiglitazone in healthy subjects.Existence of a clinically relevant interaction between clopidogrel and HMG-CoA reductase inhibitors? Re-evaluating the evidence.Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey.Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patientsSafety and Potential Effect of a Single Intracavernous Injection of Autologous Adipose-Derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-Label Phase I Clinical Trial.Use of tricyclic antidepressants and risk of glioma: a nationwide case-control study.Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres.Use of SSRIs among Danish children: a nationwide study.Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review.Relapse Prevention in Major Depressive Disorder After Successful Acute Electroconvulsive Treatment: a 6-month Double-blind Comparison of Three Fixed Dosages of Escitalopram and a Fixed Dose of Nortriptyline - Lessons from a Failed Randomised Trial oFirst-trimester exposure to methylphenidate: a population-based cohort study.The Pharmacogenetics of Tramadol.Use of psychotropic drugs during pregnancy and breast-feeding.First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.Population Exposure to Phthalate-containing Drugs.Clinical Pharmacology in Denmark in 2016 - 40 Years with the Danish Society of Clinical Pharmacology and 20 Years as a Medical Speciality.Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.Topical Antimycotics for Oral Candidiasis in Warfarin Users.Paracetamol decreases steady-state exposure to lamotrigine by induction of glucuronidation in healthy subjects.Relationship Between Time Consumption and Quality of Responses to Drug-related Queries: A Study From Seven Drug Information Centers in Scandinavia.
P50
Q26825452-043E85E0-01C2-4DE9-A211-73DB4A984B67Q26864773-2D465C7A-1D33-4CE3-9A29-F90FDC12EF2AQ28188543-209ADE4A-DCE6-4D36-8422-E45E63FF8246Q30488323-195B801E-EC51-4615-80EE-722FF029B971Q31439293-9330B970-6CDF-4C2C-93E5-92942032D17CQ33888023-BE32422C-B7B2-4048-AA5F-8CABD1718331Q34004573-A3590B26-3264-4A47-AF8E-A6DA0CE72194Q34065337-F2FA94A7-DB88-4F70-B838-6C1449CEC7D1Q34206487-77363283-56A5-4713-BE1E-80010722A14EQ34250131-3163FF16-CD2B-425A-BECD-4F68C7533702Q34347124-E9B4B9E2-F148-44A9-9368-A2A349DDB524Q34509031-2096F673-A503-4285-BF43-B088386A1C62Q34710448-A79281E0-B05B-49B6-AD40-7EABDCB47193Q34999764-55E7559F-C43D-4210-B0B6-AE235319B818Q35023736-52EDA089-9D86-46FC-90B7-F11A4287C24AQ35056229-163C0802-07EB-4B86-B3D4-10658FE779D1Q35057295-807E0F40-2041-44E1-A85D-E4437707D9E0Q35827353-C9D2AE50-57A0-421A-A35C-5635F4AF2DF2Q35827919-B903FCEB-FC93-4EF9-8CDE-97F7429B48F6Q36023598-610D4703-19F7-41E7-ABF1-0D144CBD2AFEQ36053651-1578BF43-3765-4988-87F4-134000EA5857Q36105381-06F18B01-8647-4EF8-802D-451B21595D97Q36310554-18A4EFAF-5487-472B-909A-0668910ADFF1Q36753915-E5C3F5B4-A55A-4D44-8E30-1056AB2144A4Q36964312-D114E0F4-DAD7-4A40-9164-36281AD3263AQ37742219-911568A6-A4B0-4E17-93AF-1B7F4D32C0AEQ38184948-89B1ADE9-9E89-44A8-B6F8-82C1D45E7753Q38299116-33AECC33-B710-4DE1-B1BD-538A2A12DC90Q38400866-8D954CCD-53A9-49EA-9A5C-0B8BD1723472Q38422389-EE123B22-9ACD-4148-A09C-366A66AA3B39Q38441114-0804BF8B-522A-4A6A-B0FD-CCBB81DA2A08Q38582061-3D92F70F-01C7-404E-95B2-63B5B6CC1F35Q38599005-F4A8FD42-BF0C-44B7-BC64-60CADB54C768Q38629670-22748821-4DE0-4D5B-9106-0DB9EE08735FQ38858862-FF2D64D9-807C-4834-AA8C-ED217B9A14FFQ38967948-34AB95E6-BB28-4541-BD65-48E101BBC106Q39042324-B77542F1-99B8-4047-ABC6-B49BADCEF2E3Q39143375-86174C87-29DF-4EC4-B3A7-1C1BBB0051CEQ39221329-05F55875-0D30-4B2F-A618-FFCD23BB496EQ39638706-C607EA00-2147-45D9-8AB3-3A7C882CC6BA
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Per Damkier
@ast
Per Damkier
@en
Per Damkier
@es
Per Damkier
@nl
Per Damkier
@sl
type
label
Per Damkier
@ast
Per Damkier
@en
Per Damkier
@es
Per Damkier
@nl
Per Damkier
@sl
prefLabel
Per Damkier
@ast
Per Damkier
@en
Per Damkier
@es
Per Damkier
@nl
Per Damkier
@sl
P214
P106
P1153
6603130537
P21
P214
P31
P496
0000-0003-0591-7187
P734
P735
P7859
viaf-307228123